These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35907506)

  • 21. COVID-19 and diabetes: What have we learned so far?
    Taher N; Huda MS; Chowdhury TA
    Clin Med (Lond); 2020 Jul; 20(4):e87-e90. PubMed ID: 32628128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased Risk of COVID-19 in Patients with Diabetes Mellitus-Current Challenges in Pathophysiology, Treatment and Prevention.
    Gęca T; Wojtowicz K; Guzik P; Góra T
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of Paternalistic Policies During COVID-19 on Vulnerable Populations.
    Egeolu M; Stoff B; Blalock TW
    J Natl Med Assoc; 2021 Jun; 113(3):294-296. PubMed ID: 33349470
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
    Ceriello A; Schnell O
    J Diabetes Sci Technol; 2020 Jul; 14(4):723-724. PubMed ID: 32475168
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 and diabetes: Knowledge in progress.
    Hussain A; Bhowmik B; do Vale Moreira NC
    Diabetes Res Clin Pract; 2020 Apr; 162():108142. PubMed ID: 32278764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 (COVID-19) infection.
    Wu J; Zhang J; Sun X; Wang L; Xu Y; Zhang Y; Liu X; Dong C
    Diabetes Obes Metab; 2020 Oct; 22(10):1907-1914. PubMed ID: 32496012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.
    Angelidi AM; Belanger MJ; Mantzoros CS
    Metabolism; 2020 Jun; 107():154245. PubMed ID: 32320742
    [No Abstract]   [Full Text] [Related]  

  • 28. How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit.
    Zhang JY; Shang T; Ahn D; Chen K; Coté G; Espinoza J; Mendez CE; Spanakis EK; Thompson B; Wallia A; Wisk LE; Kerr D; Klonoff DC
    J Diabetes Sci Technol; 2021 Mar; 15(2):478-514. PubMed ID: 33476193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. One year into the clash of pandemics of diabetes and COVID-19: Lessons learnt and future perspectives.
    Lui DTW; Lee CH; Tan KCB
    J Diabetes Investig; 2022 Jan; 13(1):19-21. PubMed ID: 34375500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes and hypertension as factors associated with Covid-19 lethality in Sonora, Mexico, 2020].
    Álvarez-López DI; Espinoza-Molina MP; Cruz-Loustaunau ID; Álvarez-Hernández G
    Salud Publica Mex; 2020; 62(5):456-457. PubMed ID: 33027852
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: COVID-19 and diabetes, volume II.
    Ali H; Abu-Farha M; Hofmann S
    Front Endocrinol (Lausanne); 2023; 14():1136997. PubMed ID: 36726739
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
    Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
    Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us.
    Stoian AP; Kempler P; Stulnig T; Rizvi AA; Rizzo M
    Metab Syndr Relat Disord; 2022 Apr; 20(3):137-140. PubMed ID: 34967689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-COVID syndrome, inflammation, and diabetes.
    Rizvi AA; Kathuria A; Al Mahmeed W; Al-Rasadi K; Al-Alawi K; Banach M; Banerjee Y; Ceriello A; Cesur M; Cosentino F; Galia M; Goh SY; Janez A; Kalra S; Kempler P; Lessan N; Lotufo P; Papanas N; Santos RD; Stoian AP; Toth PP; Viswanathan V; Rizzo M;
    J Diabetes Complications; 2022 Nov; 36(11):108336. PubMed ID: 36228563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.
    Barrett CE; Koyama AK; Alvarez P; Chow W; Lundeen EA; Perrine CG; Pavkov ME; Rolka DB; Wiltz JL; Bull-Otterson L; Gray S; Boehmer TK; Gundlapalli AV; Siegel DA; Kompaniyets L; Goodman AB; Mahon BE; Tauxe RV; Remley K; Saydah S
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):59-65. PubMed ID: 35025851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience.
    de Kreutzenberg SV
    High Blood Press Cardiovasc Prev; 2022 Jul; 29(4):319-326. PubMed ID: 35579849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of eHealth for the Care of Patients With Diabetes in Connection to the COVID-19 Pandemic.
    Jendle J
    J Diabetes Sci Technol; 2020 Jul; 14(4):739-740. PubMed ID: 32375494
    [No Abstract]   [Full Text] [Related]  

  • 38. Covid-19 and Diabetes Mellitus.
    Attri B; Gupta Y; Tandon N
    Natl Med J India; 2021; 34(3):129-131. PubMed ID: 34825533
    [No Abstract]   [Full Text] [Related]  

  • 39. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
    Fleming N; Sacks LJ; Pham CT; Neoh SL; Ekinci EI
    Diabet Med; 2021 Mar; 38(3):e14509. PubMed ID: 33377213
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.